Recent insider trading activity from McCormac Paul, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | McCormac Paul | Chief Technical Officer | C | Common Stock | 3191 | $0.00 | 17,349.0000 | 0 | 22.54% | 0.00% |
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | McCormac Paul | Chief Technical Officer | C | Series B convertible preferred stock | 29061 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |